Adverse events of interest in patients with axSpA receiving JAKi include infections (especially herpes zoster); venous thromboembolism; and specific laboratory abnormalities, such as elevated CPK or lipid parameters [25]. The gene discussed is PIK3C2A; the disease is infection.